Get started
Author

Kiyotoshi Imai

Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients
2014 · R Kihara, Y Nagata, et al. · Leukemia · 254
Selective secretion of chemoattractants for haemopoietic progenitor cells by bone marrow endothelial cells: a possible role in homing of haemopoietic progenitor cells to bone marrow
1999 · Kiyotoshi Imai, Masanobu Kobayashi, et al. · British Journal of Haematology · 119
PDF
Selective Transendothelial Migration of Hematopoietic Progenitor Cells: A Role in Homing of Progenitor Cells
1999 · Kiyotoshi Imai, Masanobu Kobayashi, et al. · Blood · 107
Reduction in adverse reactions to platelets by the removal of plasma supernatant and resuspension in a new additive solution (M‐sol)
2008 · Hiroshi Azuma, Junichi Hirayama, et al. · Transfusion · 105
Deeper molecular response is a predictive factor for treatment-free remission after imatinib discontinuation in patients with chronic phase chronic myeloid leukemia: the JALSG-STIM213 study
2017 · The Japan Adult Leukemia Study Group, Naoto Takahashi, et al. · International Journal of Hematology · 99
High-dose methotrexate therapy significantly improved survival of adult acute lymphoblastic leukemia: a phase III study by JALSG
2017 · for the Japan Adult Leukemia Study Group (JALSG), T Sakura, et al. · Leukemia · 86
Impact of MRD and TKI on allogeneic hematopoietic cell transplantation for Ph+ALL: a study from the adult ALL WG of the JSHCT
2015 · S Nishiwaki, K Imai, et al. · Bone Marrow Transplantation · 86
Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia
2017 · E Togasaki, J Takeda, et al. · Blood Cancer Journal · 62
PDF
Pretransplant administration of imatinib for allo-HSCT in patients with BCR-ABL–positive acute lymphoblastic leukemia
2014 · Shuichi Mizuta, Keitaro Matsuo, et al. · Blood · 59
Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study
2018 · Yasuhiko Harada, Yasunobu Nagata, et al. · Leukemia Research · 52
PDF
Long‐term outcome following imatinib therapy for chronic myelogenous leukemia, with assessment of dosage and blood levels: the JALSG CML202 study
2012 · Kazunori Ohnishi, Chiaki Nakaseko, et al. · Cancer Science · 44
PDF
Differential effects of the immunosuppressants cyclosporin A, FK506 and KM2210 on cytokine gene expression.
1995 · C W Han, M Imamura, et al. · PubMed · 43
JAK2V617F mutation status and allele burden in classical Ph-negative myeloproliferative neoplasms in Japan
2014 · Yoko Edahiro, Soji Morishita, et al. · International Journal of Hematology · 36
Impact of a donor source on adult Philadelphia chromosome-negative acute lymphoblastic leukemia: a retrospective analysis from the Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation
2013 · S. Nishiwaki, K. Miyamura, et al. · Annals of Oncology · 36
PDF
Prognostic factors influencing clinical outcome of allogeneic hematopoietic stem cell transplantation following imatinib-based therapy in BCR–ABL-positive ALL
2012 · S Mizuta, K Matsuo, et al. · Blood Cancer Journal · 31
PDF
Mediastinal emphysema and bilateral pneumothoraces with chronic GVHD in patients after allogeneic stem cell transplantation
2004 · T Toubai, J Tanaka, et al. · Bone Marrow Transplantation · 30
Phase II study of imatinib‐based chemotherapy for newly diagnosed BCR‐ABL‐positive acute lymphoblastic leukemia
2017 · Shin Fujisawa, Shuichi Mizuta, et al. · American Journal of Hematology · 29
PDF
Clinical usefulness of WT1 mRNA expression in bone marrow detected by a new WT1 mRNA assay kit for monitoring acute myeloid leukemia: a comparison with expression of WT1 mRNA in peripheral blood
2015 · Kunio Kitamura, Takahiro Nishiyama, et al. · International Journal of Hematology · 29
Clinical evaluation of WT1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes
2012 · Yasunori Ueda, Chisato Mizutani, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 28
Clinical significance of ASXL2 and ZBTB7A mutations and C-terminally truncated RUNX1-RUNX1T1 expression in AML patients with t(8;21) enrolled in the JALSG AML201 study
2018 · Naomi Kawashima, Akimi Akashi, et al. · Annals of Hematology · 26
PDF
Multicenter phase II clinical trial of nilotinib for patients with imatinib-resistant or -intolerant chronic myeloid leukemia from the East Japan CML study group evaluation of molecular response and the efficacy and safety of nilotinib
2014 · Naoto Takahashi, Masatomo Miura, et al. · Biomarker Research · 25
PDF
Acute lymphoblastic leukemia: pathophysiology and current therapy.
2017 · Kiyotoshi Imai · PubMed · 23
Prognostic value of genetic mutations in adolescent and young adults with acute myeloid leukemia
2017 · Yachiyo Kuwatsuka, Daisuke Tomizawa, et al. · International Journal of Hematology · 19
Comparison of Cord Blood Transplantation with Unrelated Bone Marrow Transplantation in Patients Older than Fifty Years
2014 · Masatsugu Tanaka, Koichi Miyamura, et al. · Transplantation and Cellular Therapy · 18
Repeated donor lymphocyte infusions overcome a myeloid sarcoma of the stomach resulting from a relapse of acute myeloid leukemia after allogeneic cell transplantation in long-term survival of more than 10 years
2010 · Akinori Wada, Naoki Kobayashi, et al. · International Journal of Hematology · 18
Works count: 82
Citation count: 1,608
H-index: 22
I10-index: 30
Year
Topic
Type